Zimmer Holdings to Present at Robert W. Baird 2006 Growth Stock Conference
(WARSAW, IN) May 3, 2006—Zimmer Holdings, Inc. (NYSE and SWX: ZMH), a leader in the orthopaedics industry, announced today it will be participating in the Robert W. Baird 2006 Growth Stock Conference in Chicago on Tuesday, May 9, 2006. Sheryl Conley, Group President, Americas and Chief Marketing Officer, and James Crines, Senior Vice President, Finance, Operations and Controller and Chief Accounting Officer, Zimmer Holdings, are scheduled to present on the Company’s business at 8:55 a.m. Central Time.
A live webcast of the presentation can be accessed via Zimmer’s Investor Relations website at http://investor.zimmer.com. The webcast will be archived for replay following the conference.
About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is the worldwide #1 pure-play orthopaedic leader in designing, developing, manufacturing and marketing reconstructive and spinal implants, trauma and related orthopaedic surgical products. Zimmer has operations in more than 24 countries around the world and sells products in more than 100 countries. Zimmer’s 2005 sales were approximately $3.3 billion. The Company is supported by the efforts of more than 6,700 employees worldwide.
###
Visit Zimmer on the worldwide web at www.zimmer.com
Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995
based on current expectations, estimates, forecasts and projections about
the orthopaedics industry, management's beliefs and assumptions made by
management. Forward-looking statements may be identified by the use of
forward-looking terms such as “may,” “will,” “expects,” “believes,”
“anticipates,” “plans,” “estimates,” “projects,” “assumes,” “guides,”
“targets,” “forecasts,” and “seeks” or the negative of such terms or other
variations on such terms or comparable terminology. These statements are not
guarantees of future performance and involve risks, uncertainties and
assumptions that could cause actual outcomes and results to differ
materially. These risks and uncertainties include, but are not limited to,
our ability to successfully integrate Centerpulse AG and Implex Corp., the
outcome of the Department of Justice investigation announced in March 2005,
price and product competition, rapid technological development, demographic
changes, dependence on new product development, the mix of our products and
services, supply and prices of raw materials and products, customer demand
for our products and services, control of costs and expenses, our ability to
form and implement alliances, international growth, governmental laws and
regulations affecting our U.S. and international businesses, including tax
obligations and risks, product liability and intellectual property
litigation losses, reimbursement levels from third-party payors, general
industry and market conditions and growth rates and general domestic and
international economic conditions including interest rate and currency
exchange rate fluctuations. For a further list and description of such
risks and uncertainties, see the disclosure materials filed by Zimmer with
the U.S. Securities and Exchange Commission. Zimmerdisclaims any intention
or obligation to update or revise any forward-looking statements, whether as
a result of new information, future events or otherwise. Readers of this
document are cautioned not to place undue reliance on these forward-looking
statements, since, while we believe the assumptions on which the
forward-looking statements are based are reasonable, there can be no
assurance that these forward-looking statements will prove to be accurate.
This cautionary statement is applicable to all forward-looking statements
contained in this document.
Contacts
Media
Brad Bishop
574-372-4291
bradley.bishop@zimmer.com
Investors
Sam Leno
574-372-4790
sam.leno@zimmer.com
Marc Ostermann
574-371-8515
marc.ostermann@zimmer.com
